AI assistant
Sending…
NeuroPace Inc — Director's Dealing 2021
Apr 20, 2021
33194_dirs_2021-04-20_f91adec0-f2af-4083-a326-699f56728efc.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroPace Inc (NPCE)
CIK: 0001528287
Period of Report: 2021-04-20
Reporting Person: LACOB JOSEPH (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 192 | Direct |
| Common Stock | 16833 | Indirect |
| Common Stock | 868 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Series A' Preferred Stock | $0.00 | Common Stock (8594) | Indirect | ||
| Series A' Preferred Stock | $0.00 | Common Stock (17189) | Indirect | ||
| Series B' Preferred Stock | $0.00 | Common Stock (102747) | Indirect | ||
| Series B' Preferred Stock | $0.00 | Common Stock (205497) | Indirect | ||
| Stock Option (Right to Buy) | $0.03 | 2022-11-12 | Common Stock (192) | Direct |
Footnotes
F1: Shares are held by Lacob Ventures LLC.
F2: Shares are held by LCT18 Investments.
F3: Each share of Preferred Stock automatically converts on a 1-for-1 basis into Common Stock at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
F4: 1/48th of the shares subject to the option vest in equal monthly installments commencing December 13, 2012.
More from NeuroPace Inc
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 21
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 24
Director's Dealing
2026
Mar 4
Annual Report
2026
Mar 3
Regulatory Filings
2026
Mar 3
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Mar 2
Director's Dealing
2026
Feb 23